By expenditures
| Name | Title | Type |
|---|---|---|
| Paula Betros | Deputy Treasurer | Auditee |
| Kevin Kerswick | Partner | Auditee |
| Chad Phillips | ASSISTANT SUPERINTENDENT OF FINANCE | Auditee |
| Matthew Scott Hunt | Signing Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 342728 | 2024 | 2025-02-18 | Crowe LLP | $38.02M |
| 17687 | 2022 | 2023-03-30 | Cliftonlarsonallen LLP | $33.04M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 17687 | 2022 | 2023-03-30 | 589370 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589369 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589368 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 589367 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589366 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589365 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 589364 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589363 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589362 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 589361 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589360 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589359 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 589358 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589357 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589356 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 589355 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589354 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589353 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 589352 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589351 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589350 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 589349 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589348 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589347 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 589346 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589345 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589344 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 589343 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589342 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589341 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 589340 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589339 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 589338 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 12928 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12927 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12926 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 12925 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12924 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12923 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 12922 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12921 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12920 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 12919 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12918 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12917 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 12916 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12915 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12914 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 12913 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12912 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12911 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 12910 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12909 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12908 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 12907 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12906 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12905 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 12904 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12903 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12902 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 12901 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12900 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12899 | 2022-002 | Significant Deficiency | Yes | C |
| 17687 | 2022 | 2023-03-30 | 12898 | 2022-004 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12897 | 2022-003 | Significant Deficiency | Yes | I |
| 17687 | 2022 | 2023-03-30 | 12896 | 2022-002 | Significant Deficiency | Yes | C |